SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Romana T. Netea-Maier, Viola Klück, Theo S. Plantinga, Johannes W. A. Smit, Autophagy in Thyroid Cancer: Present Knowledge and Future Perspectives, Frontiers in Endocrinology, 2015, 6,

    CrossRef

  2. 2
    Raktim Biswas, Arindam Mondal, Jin-Chul Ahn, Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice, Journal of Photochemistry and Photobiology B: Biology, 2015, 148, 118

    CrossRef

  3. 3
    H. Chang, B. K. Shin, A. Kim, H. K. Kim, B. H. Kim, DNA methylation analysis for the diagnosis of thyroid nodules – a pilot study with reference to BRAFV600E mutation and cytopathology results, Cytopathology, 2015, 26, 3
  4. 4
    Hongyan Liu, Zhenjie Li, Liujuan Li, Haiying Peng, Zhijun Zhang, EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression, Tumor Biology, 2015,

    CrossRef

  5. 5
    Yan-Lan Fan, Xiao-Qiu Li, Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes, Clinical Endocrinology, 2015, 83, 1
  6. 6
    Jesús Espinal-Enríquez, Said Muñoz-Montero, Ivan Imaz-Rosshandler, Aldo Huerta-Verde, Carmen Mejía, Enrique Hernández-Lemus, Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinoma, BMC Genomics, 2015, 16, 1

    CrossRef

  7. 7
    Mirela S. Petrulea, Theo S. Plantinga, Jan W. Smit, Carmen E. Georgescu, Romana T. Netea-Maier, PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma, Cancer Treatment Reviews, 2015,

    CrossRef

  8. 8
    S Beg, A K Siraj, Z Jehan, S Prabakaran, S S Al-Sobhi, M Al-Dawish, F Al-Dayel, K S Al-Kuraya, PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma, British Journal of Cancer, 2015, 112, 12, 1938

    CrossRef

  9. 9
    Ozgur Omur, Yusuf Baran, An update on molecular biology of thyroid cancers, Critical Reviews in Oncology/Hematology, 2014, 90, 3, 233

    CrossRef

  10. 10
    Soon Young Tae, Hyun-Keun Chi, Su-jin Kim, Kyu Eun Lee, Yeo-Kyu Youn, Gene Methylation Associated with Differentiated Thyroid Cancer, Journal of Korean Thyroid Association, 2014, 7, 2, 118

    CrossRef

  11. 11
    Dang Vu-Phan, Ronald J. Koenig, Genetics and epigenetics of sporadic thyroid cancer, Molecular and Cellular Endocrinology, 2014, 386, 1-2, 55

    CrossRef

  12. 12
    Hetal H. Patel, Neerav Goyal, David Goldenberg, Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer, Annals of Medicine, 2014, 46, 6, 409

    CrossRef

  13. 13
    Zhengyu He, Yuxiao Deng, Wen Li, Yongming Chen, Shunpeng Xing, Xianyuan Zhao, Jia Ding, Yuan Gao, Xiangrui Wang, Overexpression of PTEN suppresses lipopolysaccharide-induced lung fibroblast proliferation, differentiation and collagen secretion through inhibition of the PI3-K-Akt-GSK3beta pathway, Cell & Bioscience, 2014, 4, 1, 2

    CrossRef

  14. 14
    D. G. McFadden, A. Vernon, P. M. Santiago, R. Martinez-McFaline, A. Bhutkar, D. M. Crowley, M. McMahon, P. M. Sadow, T. Jacks, p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer, Proceedings of the National Academy of Sciences, 2014, 111, 16, E1600

    CrossRef

  15. 15
    Zhanna Mussazhanova, Shiro Miura, Boban Stanojevic, Tatiana Rougounovitch, Vladimir Saenko, Toshio Shiraishi, Tomomi Kurashige, Kazuko Shichijo, Kenichi Kaneko, Haruo Takahashi, Masahiro Ito, Masahiro Nakashima, Radiation-Associated Small Cell Neuroendocrine Carcinoma of the Thyroid: A Case Report with Molecular Analyses, Thyroid, 2014, 24, 3, 593

    CrossRef

  16. 16
    Wei-Zhong Xiao, Dong-Hua Han, Fei Wang, Yong-Qian Wang, You-Hou Zhu, Yi-Fang Wu, Ning-Tao Liu, Ji-Yong Sun, Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis, Tumor Biology, 2014, 35, 7, 6687

    CrossRef

  17. 17
    D. Liu, C. Yang, E. Bojdani, A. K. Murugan, M. Xing, Identification of RASAL1 as a Major Tumor Suppressor Gene in Thyroid Cancer, JNCI Journal of the National Cancer Institute, 2013, 105, 21, 1617

    CrossRef

  18. 18
    Jiao Fu, Hongjun Lv, Haixia Guan, Xiaoying Ma, Meiju Ji, Nongyue He, Bingyin Shi, Peng Hou, Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway, BMC Cancer, 2013, 13, 1, 462

    CrossRef

  19. 19
    Mingzhao Xing, Molecular pathogenesis and mechanisms of thyroid cancer, Nature Reviews Cancer, 2013, 13, 3, 184

    CrossRef

  20. 20
    John W. Kunstman, Reju Korah, James M. Healy, Manju Prasad, Tobias Carling, Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma, Surgery, 2013, 154, 6, 1255

    CrossRef

  21. 21
    J. Ngeow, C. Eng, RASAL1 in Thyroid Cancer: Wisdom From an Old Foe, JNCI Journal of the National Cancer Institute, 2013, 105, 21, 1597

    CrossRef

  22. 22
    Jieun Lee, Jung-Ah Hwang, Eun Kyung Lee, Recent Progress of Genome Study for Anaplastic Thyroid Cancer, Genomics & Informatics, 2013, 11, 2, 68

    CrossRef

  23. 23
    Roberta Granata, Laura Locati, Lisa Licitra, Therapeutic strategies in the management of patients with metastatic anaplastic thyroid cancer, Current Opinion in Oncology, 2013, 1

    CrossRef

  24. 24
    Zhihua Kang, Feng Xu, Qiao-An Zhang, Jinran Lin, Zhiyuan Wu, Xinju Zhang, Yan Luo, Jinhua Xu, Ming Guan, Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease, Modern Pathology, 2012, 25, 8, 1160

    CrossRef

  25. 25
    Yoh Dobashi, Maiko Kimura, Hirochika Matsubara, Shunsuke Endo, Johji Inazawa, Akishi Ooi, Molecular alterations in AKT and its protein activation in human lung carcinomas, Human Pathology, 2012, 43, 12, 2229

    CrossRef

  26. 26
    E. Kapiteijn, T. C. Schneider, H. Morreau, H. Gelderblom, J. W. R. Nortier, J. W. A. Smit, New treatment modalities in advanced thyroid cancer, Annals of Oncology, 2012, 23, 1, 10

    CrossRef

  27. 27
    Demao Yao, Jing Shi, Bingyin Shi, Na Wang, Wei Liu, Guanjun Zhang, Meiju Ji, Li Xu, Nongyue He, Peng Hou, Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer, Clinica Chimica Acta, 2012, 413, 7-8, 787

    CrossRef

  28. 28
    Peng Hou, Dingxie Liu, Jianli Dong, Mingzhao Xing, The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells, Cell Cycle, 2012, 11, 2, 286

    CrossRef

  29. 29
    Xiao-Lin Zhu, Zhang-Feng Wang, Wen-Bin Lei, Hui-Wen Zhuang, Wei-Jian Hou, Yi-Hui Wen, Wei-Ping Wen, Tumorigenesis role and clinical significance of DJ-1, a negative regulator of PTEN, in supraglottic squamous cell carcinoma, Journal of Experimental & Clinical Cancer Research, 2012, 31, 1, 94

    CrossRef

  30. 30
    Yae Kanai, Eri Arai, Epigenetics in Human Disease, 2012,

    CrossRef

  31. 31
    Lihong Zhang, Jing Shi, Li Xu, Bingyin Shi, Peng Hou, Meiju Ji, Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter, Thyroid Research, 2011, 4, 1, 15

    CrossRef

  32. 32
    Meiju Ji, Yong Zhang, Bingyin Shi, Peng Hou, Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC), Diagnostic Pathology, 2011, 6, 1, 48

    CrossRef

  33. 33
    P. Hou, D. Liu, M. Xing, Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells, Endocrine Related Cancer, 2011, 18, 6, 687

    CrossRef

  34. 34
    Meiju Ji, Haixia Guan, Cuixia Gao, Bingyin Shi, Peng Hou, Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC), BMC Cancer, 2011, 11, 1, 147

    CrossRef

  35. 35
    Juliane Braun, Stefan Hüttelmaier, Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin, Thyroid Research, 2011, 4, Suppl 1, S1

    CrossRef

  36. 36
    Nguyen Thi Thuy Phuong, Sang Kyum Kim, Sung Chul Lim, Hyung Sik Kim, Tae Hyung Kim, Kwang Yeol Lee, Sang-Gun Ahn, Jung-Hoon Yoon, Keon Wook Kang, Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells, Breast Cancer Research and Treatment, 2011, 130, 1, 73

    CrossRef

  37. 37
    Shannon R. Bales, Inder J. Chopra, Targeted Treatment of Differentiated and Medullary Thyroid Cancer, Journal of Thyroid Research, 2011, 2011, 1

    CrossRef

  38. 38
    Hendrieke C Hoftijzer, Ellen Kapiteijn, Tatiana Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit, Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence, Clinical Investigation, 2011, 1, 2, 241

    CrossRef

  39. 39
    Mingzhao Xing, Paul Ladenson, Thyroid Cancer, 2011,

    CrossRef

  40. 40
    V G Antico-Arciuch, M Dima, X-H Liao, S Refetoff, A Di Cristofano, Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females, Oncogene, 2010, 29, 42, 5678

    CrossRef

  41. 41
    Mingzhao Xing, Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer, Thyroid, 2010, 20, 7, 697

    CrossRef

  42. 42
    Rajeev Parameswaran, Susan Brooks, Gregory Paul Sadler, Molecular pathogenesis of follicular cell derived thyroid cancers, International Journal of Surgery, 2010, 8, 3, 186

    CrossRef

  43. 43
    Hui-Juan Zhang, Michelle Kwan-Yee Siu, Li-Li Jiang, Victor Chun-Yin Mak, Hextan Yuen-Sheung Ngan, Annie Nga-Yin Cheung, Overexpression of the Parkinson Disease Protein DJ-1 and its Regulator PTEN in Gestational Trophoblastic Disease, International Journal of Gynecological Pathology, 2010, 29, 5, 468

    CrossRef

  44. 44
    Tongsen Zheng, Xianzhi Meng, JiaBei Wang, Xi Chen, Dalong Yin, Yingjian Liang, Xuan Song, Shangha Pan, Hongchi Jiang, Lianxin Liu, PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice, Journal of Cellular Biochemistry, 2010, 111, 1
  45. 45
    Motoyasu Saji, Matthew D. Ringel, The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors, Molecular and Cellular Endocrinology, 2010, 321, 1, 20

    CrossRef

  46. 46
    Guennadi Kouniavsky, Martha A Zeiger, Thyroid tumorigenesis and molecular markers in thyroid cancer, Current Opinion in Oncology, 2010, 22, 1, 23

    CrossRef

  47. 47
    Jeffrey A Knauf, James A Fagin, Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets, Current Opinion in Cell Biology, 2009, 21, 2, 296

    CrossRef